JP2007500132A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007500132A5 JP2007500132A5 JP2006521282A JP2006521282A JP2007500132A5 JP 2007500132 A5 JP2007500132 A5 JP 2007500132A5 JP 2006521282 A JP2006521282 A JP 2006521282A JP 2006521282 A JP2006521282 A JP 2006521282A JP 2007500132 A5 JP2007500132 A5 JP 2007500132A5
- Authority
- JP
- Japan
- Prior art keywords
- ldcam
- crtam
- polypeptide
- dendritic cell
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49002703P | 2003-07-25 | 2003-07-25 | |
| PCT/US2004/023822 WO2005012530A2 (en) | 2003-07-25 | 2004-07-23 | Antagonists and agonists of ldcam and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007500132A JP2007500132A (ja) | 2007-01-11 |
| JP2007500132A5 true JP2007500132A5 (https=) | 2007-09-06 |
Family
ID=34115346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521282A Pending JP2007500132A (ja) | 2003-07-25 | 2004-07-23 | Ｌｄｃａｍのアンタゴニストおよびアゴニスト、並びにその使用法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7267960B2 (https=) |
| EP (2) | EP1648935A2 (https=) |
| JP (1) | JP2007500132A (https=) |
| AT (1) | ATE554108T1 (https=) |
| AU (1) | AU2004261941B2 (https=) |
| CA (1) | CA2533512C (https=) |
| ES (1) | ES2383328T3 (https=) |
| MX (1) | MXPA06000974A (https=) |
| WO (1) | WO2005012530A2 (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7727221B2 (en) | 2001-06-27 | 2010-06-01 | Cardiac Pacemakers Inc. | Method and device for electrochemical formation of therapeutic species in vivo |
| EP1860119B1 (en) * | 2005-02-28 | 2011-08-03 | Institute for Antibodies Co., Ltd. | ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME |
| US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
| US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
| US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
| US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
| ES2625259T3 (es) | 2006-08-29 | 2017-07-19 | Oxford Biotherapeutics Ltd | Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón |
| CA2663220A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
| WO2008034048A2 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprosthesis with biostable inorganic layers |
| WO2008034047A2 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Endoprosthesis with adjustable surface features |
| WO2008034066A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making the same |
| US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
| US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
| WO2008083190A2 (en) | 2006-12-28 | 2008-07-10 | Boston Scientific Limited | Bioerodible endoprostheses and methods of making same |
| KR20100067089A (ko) * | 2007-08-30 | 2010-06-18 | 제넨테크, 인크. | Ｔ 세포를 조정하기 위한 방법 및 조성물 |
| US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
| US10457719B2 (en) * | 2007-09-18 | 2019-10-29 | The Jackson Laboratory | Antibodies and FC fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| GB2455634A (en) * | 2007-12-20 | 2009-06-24 | Ucb Pharma Sa | Treatment of cancer |
| US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
| US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
| US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
| US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
| WO2010101901A2 (en) | 2009-03-02 | 2010-09-10 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
| US8420084B2 (en) | 2009-03-05 | 2013-04-16 | Medarex, Inc. | Fully human antibodies specific to CADM1 |
| SG178064A1 (en) * | 2009-07-21 | 2012-03-29 | Abt Holding Co | Use of stem cells to reduce leukocyte extravasation |
| EP2456860B1 (en) * | 2009-07-21 | 2018-09-05 | ABT Holding Company | Use of stem cells to reduce leukocyte extravasation |
| US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
| UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| WO2014144817A2 (en) | 2013-03-15 | 2014-09-18 | Amgen Inc. | Inhibitory polypeptides specific to wnt inhibitors |
| EP3712166A1 (en) | 2013-09-05 | 2020-09-23 | Amgen Inc. | Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles |
| US10156562B2 (en) | 2014-05-16 | 2018-12-18 | Amgen Inc. | Assay for detecting Th1 and Th2 cell populations |
| GB2538666A (en) * | 2014-07-21 | 2016-11-23 | Delinia Inc | Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases |
| US20170022286A1 (en) * | 2015-03-23 | 2017-01-26 | The Board Of Trustees Of The Leland Stanford Junior University | Medical uses of crtam agonists |
| EP3294397B1 (en) * | 2015-05-13 | 2024-07-10 | Innoventions Ltd. | System for inhibiting biofilm formation on catheters |
| US20170204154A1 (en) * | 2016-01-20 | 2017-07-20 | Delinia, Inc. | Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases |
| US11077172B2 (en) | 2016-11-08 | 2021-08-03 | Delinia, Inc. | IL-2 variants for the treatment of psoriasis |
| AU2018235928B2 (en) | 2017-03-14 | 2023-09-21 | Amgen Inc. | Control of total afucosylated glycoforms of antibodies produced in cell culture |
| AU2018361819B2 (en) * | 2017-11-02 | 2025-01-09 | Oxford Biotherapeutics Ltd | Antibodies and methods of use |
| CN108333132A (zh) * | 2018-02-22 | 2018-07-27 | 哈尔滨工业大学 | 一种煤化工废水的生物毒性检测方法 |
| BR112020019559A2 (pt) | 2018-03-26 | 2021-01-12 | Amgen Inc. | Glicoformas afucosiladas totais de anticorpos produzidos em cultura de células |
| MX2022003461A (es) | 2019-09-26 | 2022-04-19 | Amgen Inc | Metodos de produccion de composiciones de anticuerpos. |
| WO2021247892A1 (en) | 2020-06-04 | 2021-12-09 | Amgen Inc. | Assessment of cleaning procedures of a biotherapeutic manufacturing process |
| AU2021360897A1 (en) | 2020-10-15 | 2023-05-25 | Amgen Inc. | Relative unpaired glycans in antibody production methods |
| EP4232079A4 (en) * | 2020-10-20 | 2024-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | INJECTABLE HYDROGELS FOR ADOPTIVE CELL THERAPY |
| EP4352094A1 (en) | 2021-06-07 | 2024-04-17 | Amgen Inc. | Using fucosidase to control afucosylation level of glycosylated proteins |
| TW202317631A (zh) * | 2021-06-30 | 2023-05-01 | 大陸商南京聖和藥業股份有限公司 | 抗crtam抗體及其應用 |
| AU2022361382A1 (en) | 2021-10-05 | 2024-03-28 | Amgen Inc. | Fc-gamma receptor ii binding and glycan content |
| WO2023215725A1 (en) | 2022-05-02 | 2023-11-09 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
| WO2024220916A1 (en) | 2023-04-20 | 2024-10-24 | Amgen Inc. | Methods of determining relative unpaired glycan content |
| WO2025038600A1 (en) | 2023-08-14 | 2025-02-20 | Amgen Inc. | Methods for reducing yellow color |
| WO2025101820A1 (en) | 2023-11-08 | 2025-05-15 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4411993A (en) | 1981-04-29 | 1983-10-25 | Steven Gillis | Hybridoma antibody which inhibits interleukin 2 activity |
| US4474893A (en) | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4546082A (en) | 1982-06-17 | 1985-10-08 | Regents Of The Univ. Of California | E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins |
| US4737462A (en) | 1982-10-19 | 1988-04-12 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
| US4703004A (en) | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
| DE3586772T2 (de) | 1984-07-24 | 1993-03-04 | Coselco Mimotopes Pty Ltd | Verfahren zur bestimmung von mimotopen. |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US5391485A (en) | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5071972A (en) | 1986-01-31 | 1991-12-10 | Genetics Institute, Inc. | DNA sequences encoding novel thrombolytic proteins |
| US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
| US5011912A (en) | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| EP0276846A3 (en) | 1987-01-29 | 1989-07-26 | Zymogenetics, Inc. | Colony-stimulating factor derivatives |
| US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
| US4965195A (en) | 1987-10-26 | 1990-10-23 | Immunex Corp. | Interleukin-7 |
| DE3889853D1 (de) | 1987-11-05 | 1994-07-07 | Hybritech Inc | Polysaccharidmodifizierte Immunglobuline mit reduziertem immunogenem Potential oder verbesserter Pharmakokinetik. |
| US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
| CA1340772C (en) | 1987-12-30 | 1999-09-28 | Patricia Tekamp-Olson | Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences |
| US6010902A (en) | 1988-04-04 | 2000-01-04 | Bristol-Meyers Squibb Company | Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity |
| WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| DE3909708A1 (de) | 1989-03-23 | 1990-09-27 | Boehringer Mannheim Gmbh | Verfahren zur herstellung bispezifischer antikoerper |
| US5073627A (en) | 1989-08-22 | 1991-12-17 | Immunex Corporation | Fusion proteins comprising GM-CSF and IL-3 |
| US5126323A (en) | 1989-11-16 | 1992-06-30 | Genetics Institute, Inc. | Homogeneous purified k-fgf and compositions containing the same |
| AU651596B2 (en) | 1990-06-05 | 1994-07-28 | Immunex Corporation | Type II interleukin-1 receptors |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE300615T1 (de) | 1990-08-29 | 2005-08-15 | Genpharm Int | Transgene mäuse fähig zur produktion heterologer antikörper |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| EP0557300B1 (en) | 1990-10-29 | 1997-11-19 | Chiron Corporation | Bispecific antibodies, method of production, and uses thereof |
| US5582996A (en) | 1990-12-04 | 1996-12-10 | The Wistar Institute Of Anatomy & Biology | Bifunctional antibodies and method of preparing same |
| AU643141B2 (en) | 1991-03-15 | 1993-11-04 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
| DE4118120A1 (de) | 1991-06-03 | 1992-12-10 | Behringwerke Ag | Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| US5716805A (en) | 1991-10-25 | 1998-02-10 | Immunex Corporation | Methods of preparing soluble, oligomeric proteins |
| US5262522A (en) | 1991-11-22 | 1993-11-16 | Immunex Corporation | Receptor for oncostatin M and leukemia inhibitory factor |
| JP3560609B2 (ja) | 1992-11-13 | 2004-09-02 | イミュネックス・コーポレーション | Ｅｌｋリガンドと呼ばれる新規なサイトカイン |
| US5457035A (en) | 1993-07-23 | 1995-10-10 | Immunex Corporation | Cytokine which is a ligand for OX40 |
| DK0716610T3 (da) | 1993-08-26 | 2006-09-04 | Genetics Inst Llc | Humane knogle-morfogenetiske proteiner til anvendelse ved neural regenerering |
| DE69434651T2 (de) | 1993-12-07 | 2007-03-08 | Genetics Institute, Inc., Cambridge | Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen |
| US6407059B1 (en) | 1994-06-08 | 2002-06-18 | Peptor Limited | Conformationally constrained backbone cyclized peptide analogs |
| AU698393B2 (en) | 1994-06-24 | 1998-10-29 | Immunex Corporation | Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| US6169073B1 (en) | 1995-02-16 | 2001-01-02 | Bayer Corporation | Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5877155A (en) | 1995-03-17 | 1999-03-02 | The Research Foundation Of State University Of New York | Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| US5686257A (en) | 1995-04-26 | 1997-11-11 | Schering Corporation | Binding compositions for mammalian T cell antigens and related reagents |
| US6127977A (en) | 1996-11-08 | 2000-10-03 | Cohen; Nathan | Microstrip patch antenna with fractal structure |
| GB9601081D0 (en) | 1995-10-06 | 1996-03-20 | Cambridge Antibody Tech | Specific binding members for human transforming growth factor beta;materials and methods |
| US5824519A (en) | 1995-11-08 | 1998-10-20 | Medical University Of South Carolina | Tissue-specific and target RNA-specific ribozymes |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| US6642360B2 (en) * | 1997-12-03 | 2003-11-04 | Genentech, Inc. | Secreted polypeptides that stimulate release of proteoglycans from cartilage |
| WO1999010376A1 (en) | 1997-08-22 | 1999-03-04 | Washington University | Inducible regulatory system and use thereof |
| CA2311640A1 (en) | 1997-12-03 | 1999-06-10 | Genentech, Inc. | Polypeptides and nucleic acids encoding the same |
| US20020165143A1 (en) * | 1997-12-03 | 2002-11-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CA2314267A1 (en) | 1997-12-10 | 1999-06-17 | Washington University | Anti-pathogen system and methods of use thereof |
| JP2003525575A (ja) | 1998-05-07 | 2003-09-02 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | 分泌蛋白およびそれらをコードするポリヌクレオチド |
| IL140938A0 (en) * | 1998-08-07 | 2002-02-10 | Immunex Corp | Molecules designated b7l-1 |
| NZ510356A (en) * | 1998-08-07 | 2004-12-24 | Immunex Corp | Molecules designated LDCAM |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| WO2000029435A1 (en) | 1998-10-28 | 2000-05-25 | Human Genome Sciences, Inc. | 12 human secreted proteins |
| EP1135495A2 (en) | 1998-12-01 | 2001-09-26 | Genentech, Inc. | Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| US6787638B1 (en) | 1998-12-02 | 2004-09-07 | Applied Molecular Evolution, Inc. | Tumor specific human monoclonal antibodies and methods of use |
| JP2002531113A (ja) | 1998-12-10 | 2002-09-24 | ワシントン大学 | 蛋白質の形質導入システムおよびその使用法 |
| CA2339404A1 (en) | 1999-06-30 | 2001-01-04 | Sigma-Aldrich Co. | Synthetic peptide immunogens and antibodies thereto |
| EP1285084A1 (en) | 2000-01-25 | 2003-02-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US6596493B1 (en) * | 2000-08-15 | 2003-07-22 | The Johns Hopkins University School Of Medicine | Diagnosis and treatment of tumor-suppressor associated disorders |
| AU2001296301A1 (en) | 2000-09-26 | 2002-04-08 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| NL2002787C2 (en) | 2009-04-23 | 2010-10-26 | Medspray Xmems Bv | Atomising body, atomising device, inhaler, manufacturing method of manufacturing an atomising body and assembly method for assembling an atomising device. |
-
2004
- 2004-07-23 EP EP04779057A patent/EP1648935A2/en not_active Withdrawn
- 2004-07-23 JP JP2006521282A patent/JP2007500132A/ja active Pending
- 2004-07-23 AU AU2004261941A patent/AU2004261941B2/en not_active Ceased
- 2004-07-23 EP EP09011595A patent/EP2133362B1/en not_active Expired - Lifetime
- 2004-07-23 AT AT09011595T patent/ATE554108T1/de active
- 2004-07-23 WO PCT/US2004/023822 patent/WO2005012530A2/en not_active Ceased
- 2004-07-23 MX MXPA06000974A patent/MXPA06000974A/es active IP Right Grant
- 2004-07-23 ES ES09011595T patent/ES2383328T3/es not_active Expired - Lifetime
- 2004-07-23 CA CA2533512A patent/CA2533512C/en not_active Expired - Fee Related
- 2004-07-23 US US10/898,408 patent/US7267960B2/en not_active Expired - Fee Related
-
2007
- 2007-09-07 US US11/852,123 patent/US8043615B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007500132A5 (https=) | ||
| US20240325554A1 (en) | Methods for treating cancer | |
| US20230129258A1 (en) | Heterotandem bicyclic peptide complexes | |
| JP5651583B2 (ja) | 自己免疫疾患の治療および／または予防のための薬剤、ならびに制御性ｔ細胞形成のための薬剤 | |
| US12522660B2 (en) | Methods for selection and stimulation of cells and apparatus for same | |
| CN1136914C (zh) | 鉴定或分离分子的方法和由此鉴定的分子 | |
| CN105636982B (zh) | 用于治疗hbv感染和相关病症的结合免疫效应细胞表面抗原和hbv抗原的双或多特异性多肽 | |
| KR20200019211A (ko) | T 세포 수용체 | |
| JP2022515330A (ja) | 多量体ｔ細胞調節ポリペプチド及びその使用方法 | |
| JP2009542592A5 (https=) | ||
| JP2010527919A5 (https=) | ||
| JPH06501456A (ja) | 表面複合リンホトキシン | |
| Leonard et al. | Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity | |
| JP2007536933A5 (https=) | ||
| US20260015400A1 (en) | Methods and compositions of a follicle stimulating hormone receptor immunoreceptor or chimeric antigen receptor | |
| JPH08504170A (ja) | 進行性免疫抑制症患者の評価と治療 | |
| US20170073410A1 (en) | Monoclonal antibodies to interleukin 35 and methods of use thereof to inhibit regulatory t cell function | |
| Bezverbnaya et al. | Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma | |
| AU2001274931B2 (en) | Reagents for cell selection and methods of use | |
| CN108409830B (zh) | 一种人pd-1蛋白胞外段亲和环肽c8及其应用 | |
| CN1675242A (zh) | 促红细胞生成素中的t－细胞表位 | |
| US20110144038A1 (en) | Human cd154-binding synthetic peptide and uses thereof | |
| CN114349869B (zh) | 一种双特异性的nk细胞激动剂及制备方法和应用 | |
| EP4301388A1 (en) | Treatment | |
| ES3016662T3 (en) | Binding molecules specfic for hbv envelope protein |